Centauri Therapeutics
Centauri Therapeutics is an immunotherapy company, with a unique and proprietary platform technology applicable across a wide range of therapeutic indications. The Company’s initial focus is on infectious diseases, driven by an urgent unmet need for anti-infectives to treat the most vulnerable and at-risk patients. Centauri also has strong initial proof-of-concept data in oncology. Centauri’s Alphamer platform has a unique mechanism of action, utilising an antibody recruiting molecule to harness the body’s natural immune response, and redirect antibodies to target diseases.Content by Centauri Therapeutics
| 2 min read
The ABX-01 is a broad-spectrum antimicrobial specifically selected to combat clinically prevalent and multidrug-resistant bacterial strains.
| 3 min read
Paper presents the first pre-clinical application of endogenous antibody recruitment to address multi-drug resistant Gram-negative infections
Page 1 of 1 - 2 Total Items
